Accenture Expands Platform for Drug Discovery and Innovation with Creation of Life Sciences Partner Ecosystem
NEW YORK and LAS VEGAS; Nov. 26, 2018 – Accenture (NYSE: ACN) has created an open partner ecosystem designed to help independent software vendors (ISVs) and life sciences companies team more effectively to accelerate drug discovery efforts and, ultimately, improve patient outcomes.
Comments
Post a Comment